Recommendations for making decisions about moving from topical medication to systemic therapy for atopic dermatitis (AD) are lacking, according to a subgroup of the International Eczema Council. The group met to review the literature and provide recommendations, which stated that before moving to systemic therapy, a systematic and holistic approach should be used to assess AD’s impact on quality of life.
Read the recommendations at the Journal of the American Academy of Dermatology. (Open Access.)
Work Cited:
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council Simpson, Eric L. et al., Journal of the American Academy of Dermatology, Volume 77, Issue 4, 623-633